Clinical Trial Update: Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term safety and efficacy of prolonged-release tacrolimus (FK506E-MR4) in transplant recipients when used with other immunosuppress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation
• Kidney Transplantation
• Liver Transplantation

Drugs mentioned

• Tacrolimus extended-release (FK506E-MR4) (Tacrolimus extended-release)

Snippet

Sponsor: Astellas Pharma Europe Ltd. | Conditions: Heart Transplantation, Liver Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2016-03-15